IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $179K invested in Innate Pharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$93K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$46.6K |
| 3 |
GI
3
GAMMA Investing
Foster City,
California
|
$6.27K |
| 4 |
PS
4
Principal Securities
Des Moines,
Iowa
|
$82 |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $93K | 51,224 | +7,700 | +18% |
|
|
2
Citadel Advisors
Miami,
Florida
| $46.6K | 26,617 | +2,350 | +10% |
|
3
Millennium Management
New York
| $20.4K | 11,661 | -3,665 | -24% |
|
4
UBS Group
Zurich,
Switzerland
| $10.8K | 5,957 | -3,044 | -34% |
|
|
GI
5
GAMMA Investing
Foster City,
California
| $6.27K | 3,456 | +1,223 | +55% |
|
6
Barclays
London,
United Kingdom
| $1K | 307 | – | – |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $822 | 470 | -205 | -30% |
|
8
Optiver Holding
Amsterdam,
Netherlands
| $177 | 101 | – | – |
|
|
PS
9
Principal Securities
Des Moines,
Iowa
| $82 | 45 | +45 | New |
|
|
ETC
10
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| – | – | -62,752 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | – | -3 | Closed |
|